A functional assay tests what a genetic change does in a particular system. The result needs to fit the question about disease, and it does not automatically identify a useful treatment.
ClinGen's primary recommendations for functional variant evidence evaluate disease mechanism, assay relevance, assay validation and the evidence for an individual variant. An abnormal assay result needs controls and evidence that the measured function is relevant to the disease mechanism. The PS3/BS3 framework concerns sequence-variant interpretation; it is not a cancer-drug actionability score. Treatment claims require evidence for the exact alteration, disease and intervention context.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/